Pnc Financial Services Group, Inc. Tg Therapeutics, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $150 Billion
- Q2 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 3,554 shares of TGTX stock, worth $84,691. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,554
Previous 3,553
0.03%
Holding current value
$84,691
Previous $54,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding TGTX
# of Institutions
287Shares Held
91.8MCall Options Held
1.9MPut Options Held
1.45M-
Vanguard Group Inc Valley Forge, PA13.7MShares$326 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$271 Million0.0% of portfolio
-
State Street Corp Boston, MA6.7MShares$160 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.65MShares$86.9 Million6.57% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V83.24MShares$77.3 Million0.07% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $3.46B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...